Literature DB >> 18293069

Primary immunodeficiencies unravel critical aspects of the pathophysiology of autoimmunity and of the genetics of autoimmune disease.

Antonio Coutinho1, Magda Carneiro-Sampaio.   

Abstract

BACKGROUND: Primary Immunodeficiencies (PIDs) represent unique opportunities to understand the operation of the human immune system. Accordingly, PIDs associated with autoimmune manifestations provide insights into the pathophysiology of autoimmunity as well as into the genetics of autoimmune diseases (AID). Epidemiological data show that there are PIDs systematically associated with AID, such as immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX), Omenn syndrome, autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), autoimmune lymphoproliferative syndrome (ALPS), and C1q deficiency, while strong associations are seen with a handful of other deficits.
CONCLUSION: We interpret such stringent disease associations, together with a wealth of observations in experimental systems, as indicating first of all that natural tolerance to body components is an active, dominant process involving many of the components that ensure responsiveness, rather than, as previously believed, the result of the mere purge of autoreactivities. More precisely, it seems that deficits of Treg cell development, functions, numbers, and T cell receptor repertoire are among the main factors for autoimmunity pathogenesis in many (if not all) PIDs most frequently presenting with autoimmune features. Clearly, other pathophysiological mechanisms are also involved in autoimmunity, but these seem less critical in the process of self-tolerance. Comparing the clinical picture of IPEX cases with those, much less severe, of ALPS or APECED, provides some assessment of the relative importance of each set of mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18293069     DOI: 10.1007/s10875-007-9167-y

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  21 in total

Review 1.  The role of regulatory T cells in allergy.

Authors:  Maria A Curotto de Lafaille; Juan J Lafaille
Journal:  Springer Semin Immunopathol       Date:  2003-10-22

2.  Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease.

Authors:  Joshua D Milner; Jerrold M Ward; Andrea Keane-Myers; William E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-03       Impact factor: 11.205

Review 3.  Autoimmunity, microbial immunity and the immunological homunculus.

Authors:  I R Cohen; D B Young
Journal:  Immunol Today       Date:  1991-04

Review 4.  RAG-dependent primary immunodeficiencies.

Authors:  Cristina Sobacchi; Veronica Marrella; Francesca Rucci; Paolo Vezzoni; Anna Villa
Journal:  Hum Mutat       Date:  2006-12       Impact factor: 4.878

5.  Cutting edge: Decreased accumulation and regulatory function of CD4+ CD25(high) T cells in human STAT5b deficiency.

Authors:  Aileen C Cohen; Kari C Nadeau; Wenwei Tu; Vivian Hwa; Kira Dionis; Liliana Bezrodnik; Alejandro Teper; Maria Gaillard; Juan Heinrich; Alan M Krensky; Ron G Rosenfeld; David B Lewis
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

6.  Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model.

Authors:  Khie Khiong; Masaaki Murakami; Chika Kitabayashi; Naoko Ueda; Shin-ichiro Sawa; Akemi Sakamoto; Brian L Kotzin; Stephen J Rozzo; Katsuhiko Ishihara; Marileila Verella-Garcia; John Kappler; Philippa Marrack; Toshio Hirano
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 7.  Murine models of Omenn syndrome.

Authors:  Serre-Yu Wong; David B Roth
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

8.  Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.

Authors:  Raif S Geha; Luigi D Notarangelo; Jean-Laurent Casanova; Helen Chapel; Mary Ellen Conley; Alain Fischer; Lennart Hammarström; Shigeaki Nonoyama; Hans D Ochs; Jennifer M Puck; Chaim Roifman; Reinhard Seger; Josiah Wedgwood
Journal:  J Allergy Clin Immunol       Date:  2007-10       Impact factor: 10.793

9.  NRAS mutation causes a human autoimmune lymphoproliferative syndrome.

Authors:  João B Oliveira; Nicolas Bidère; Julie E Niemela; Lixin Zheng; Keiko Sakai; Cynthia P Nix; Robert L Danner; Jennifer Barb; Peter J Munson; Jennifer M Puck; Janet Dale; Stephen E Straus; Thomas A Fleisher; Michael J Lenardo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-16       Impact factor: 11.205

10.  A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome.

Authors:  Veronica Marrella; Pietro Luigi Poliani; Anna Casati; Francesca Rucci; Laura Frascoli; Marie-Lise Gougeon; Brigitte Lemercier; Marita Bosticardo; Maria Ravanini; Manuela Battaglia; Maria Grazia Roncarolo; Marina Cavazzana-Calvo; Fabio Facchetti; Luigi D Notarangelo; Paolo Vezzoni; Fabio Grassi; Anna Villa
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

View more
  7 in total

1.  CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model.

Authors:  Pushpa Pandiyan; Heather R Conti; Lixin Zheng; Alanna C Peterson; Douglas R Mathern; Nydiaris Hernández-Santos; Mira Edgerton; Sarah L Gaffen; Michael J Lenardo
Journal:  Immunity       Date:  2011-03-25       Impact factor: 31.745

Review 2.  Autoimmunity in immunodeficiency.

Authors:  Krista Todoric; Jessica B Koontz; Daniel Mattox; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

3.  Mutations in a gene encoding a midbody protein in binucleated Reed-Sternberg cells of Hodgkin lymphoma.

Authors:  Maxwell M Krem; Stephen J Salipante; Marshall S Horwitz
Journal:  Cell Cycle       Date:  2010-03-02       Impact factor: 4.534

4.  The molecular mechanisms of regulatory T cell immunosuppression.

Authors:  Pushpa Pandiyan; Lixin Zheng; Michael J Lenardo
Journal:  Front Immunol       Date:  2011-11-24       Impact factor: 7.561

5.  Systemic lupus erythematosus, progressive multifocal leukoencephalopathy, and T-CD4+ lymphopenia.

Authors:  Mariana Brandão; Joana Damásio; António Marinho; Ana Martins da Silva; Júlia Vasconcelos; Esmeralda Neves; Isabel Almeida; Fátima Farinha; Carlos Vasconcelos
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 10.817

6.  Rituximab resistant evans syndrome and autoimmunity in Schimke immuno-osseous dysplasia.

Authors:  Jakub Zieg; Anna Krepelova; Alireza Baradaran-Heravi; Elena Levtchenko; Encarna Guillén-Navarro; Miroslava Balascakova; Martina Sukova; Tomas Seeman; Jiri Dusek; Nadezda Simankova; Tomas Rosik; Sylva Skalova; Jan Lebl; Cornelius F Boerkoel
Journal:  Pediatr Rheumatol Online J       Date:  2011-09-13       Impact factor: 3.054

7.  CD4(+) CD25(+) cells in type 1 diabetic patients with other autoimmune manifestations.

Authors:  Dalia S Abd Elaziz; Mona H Hafez; Nermeen M Galal; Safa S Meshaal; Aisha M El Marsafy
Journal:  J Adv Res       Date:  2013-09-26       Impact factor: 10.479

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.